Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SNN
stocks logo

SNN

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2029Q1
FY2029Q2
FY2029Q3
1.52B
+5.68%
--
--
1.51B
+6.85%
--
--
1.68B
+7.06%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Smith & Nephew plc (SNN) for FY2025, with the revenue forecasts being adjusted by 0.65% over the past three months. During the same period, the stock price has changed by 0.67%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.65%
In Past 3 Month
Stock Price
Go Up
up Image
+0.67%
In Past 3 Month
2 Analyst Rating
up Image0
Wall Street analysts forecast SNN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNN is 28.63 USD with a low forecast of 28.00 USD and a high forecast of 29.26  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
up Image0
Current: 28.580
sliders
Low
28.00
Averages
28.63
High
29.26
up Image0
Current: 28.580
sliders
Low
28.00
Averages
28.63
High
29.26
Citi
Buy
maintain
2025-06-05
Reason
Citi
Price Target
2025-06-05
maintain
Buy
Reason
Citi raised the firm's price target on Smith & Nephew to 1,450 GBp from 1,425 GBp and keeps a Buy rating on the shares.
HSBC
Buy
to
Hold
downgrade
2025-04-25
Reason
HSBC
Price Target
2025-04-25
downgrade
Buy
to
Hold
Reason
HSBC downgraded Smith & Nephew to Hold from Buy with a price target of 1,070 GBp, down from 1,160 GBp. The firm adjusted ratings in medical technology and life sciences are quantifying the risk/reward using stagflation, weak macro environment, and recovery scenario analyses. The market is debating whether the recent multiples correction is an opportunity to buy, or if it is the start of a potential recession, the analyst tells investors in a research note. HSBC's analysis of historical sector multiples reveals that the multiples compression might have an additional 20%-25% downside in a stagflation scenario. "We are far from the point where one can argue that these stocks are pricing in a recession," contends HSBC.
Canaccord Genuity
Caitlin Cronin
Hold
Maintains
$27
2025-03-17
Reason
Canaccord Genuity
Caitlin Cronin
Price Target
$27
2025-03-17
Maintains
Hold
Reason
UBS
Graham Doyle
Strong Buy
to
Hold
Downgrades
n/a
2025-03-12
Reason
UBS
Graham Doyle
Price Target
n/a
2025-03-12
Downgrades
Strong Buy
to
Hold
Reason
Canaccord Genuity
Kyle Rose
Hold
Maintains
$27
2025-02-26
Reason
Canaccord Genuity
Kyle Rose
Price Target
$27
2025-02-26
Maintains
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Smith & Nephew PLC (SNN.N) is 14.98, compared to its 5-year average forward P/E of 18.16. For a more detailed relative valuation and DCF analysis to assess Smith & Nephew PLC 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
18.16
Current PE
14.98
Overvalued PE
21.90
Undervalued PE
14.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
11.37
Current EV/EBITDA
10.10
Overvalued EV/EBITDA
13.44
Undervalued EV/EBITDA
9.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.50
Current PS
2.15
Overvalued PS
3.10
Undervalued PS
1.89

Financials

Annual
Quarterly

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 225.52% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

SNN News & Events

Events Timeline

(ET)
2025-06-18
05:06:09
Smith & Nephew partners with Standard Health
select
2025-05-27 (ET)
2025-05-27
10:08:02
Smith & Nephew awarded contract for Negative Pressure Wound Therapy systems
select
2025-05-14 (ET)
2025-05-14
08:20:45
Smith & Nephew announces findings from study of sNPWT devices
select
Sign Up For More Events
Sign Up For More Events

News

Preview
5.0
06-09Newsfilter
New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

  • Introduction of New Product: Smith+Nephew has launched a new medial stabilized insert for its LEGION Total Knee System, reflecting a significant shift in knee arthroplasty trends towards designs that offer more natural kinematics and higher patient satisfaction.

  • Market Impact and Future Plans: The new insert is expected to enhance the LEGION portfolio's appeal as demand for advanced knee solutions grows, with limited availability in the US now and a full commercial release planned for 2025.

Preview
4.0
06-06NASDAQ.COM
SNN Crosses Above Average Analyst Target

  • Stock Performance: Smith & Nephew plc shares have surpassed the average analyst 12-month target price of $29.85, currently trading at $30.30, prompting analysts to consider either downgrading their valuation or raising their target prices based on company performance.

  • Analyst Insights: The average target price is influenced by various analysts, with estimates ranging from $27.71 to $33.00, indicating a diverse outlook on the stock's potential and encouraging investors to evaluate whether to hold or sell their shares.

Preview
6.0
05-27Newsfilter
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

  • Smith+Nephew Contract with U.S. DoD: Smith+Nephew has been awarded a 10-year contract worth up to $75 million by the U.S. Department of Defense to supply its RENASYS TOUCH Negative Pressure Wound Therapy Systems, which are designed for military medical providers to enhance wound care in various settings.

  • Partnership with U.S. Army Institute: In 2024, Smith+Nephew entered into a Master Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to innovate wound and burn care within the military healthcare system, continuing their long-standing support for military medical needs.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Smith & Nephew PLC (SNN) stock price today?

The current price of SNN is 28.58 USD — it has decreased -0.17 % in the last trading day.

arrow icon

What is Smith & Nephew PLC (SNN)'s business?

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

arrow icon

What is the price predicton of SNN Stock?

Wall Street analysts forecast SNN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNN is 28.63 USD with a low forecast of 28.00 USD and a high forecast of 29.26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Smith & Nephew PLC (SNN)'s revenue for the last quarter?

Smith & Nephew PLC revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Smith & Nephew PLC (SNN)'s earnings per share (EPS) for the last quarter?

Smith & Nephew PLC. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Smith & Nephew PLC (SNN)'s fundamentals?

The market is revising Upward the revenue expectations for Smith & Nephew plc (SNN) for FY2025, with the revenue forecasts being adjusted by 0.65% over the past three months. During the same period, the stock price has changed by 0.67%.
arrow icon

How many employees does Smith & Nephew PLC (SNN). have?

Smith & Nephew PLC (SNN) has 17349 emplpoyees as of June 20 2025.

arrow icon

What is Smith & Nephew PLC (SNN) market cap?

Today SNN has the market capitalization of 12.52B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free